28th Sep 2006 14:00
Bespak PLC28 September 2006 Bespak plc Annual General Meeting Bespak plc, a leader in medical devices for inhaled drug delivery and anaesthesia will have its AGM today. John Robinson, Chairman, will say: "Last year was excellent for Bespak. Revenues increased 17% and operating profitbefore special items increased 34%. Our core Inhaled Drug Delivery businessesexceeded expectations, production began on the inhaler for Exubera(R), theworld's first inhaled insulin, and King Systems was acquired. "In the current financial year, which began 30 April 2006, trading has beenstrong across all Bespak's businesses, and King Systems, acquired in December2005, has been successfully integrated. The withdrawal from the ConsumerDispensers business, announced in August, is proceeding as planned." "I am also pleased to welcome Jon Glenn to the Board as Finance Director. Jonjoined the Group at the beginning of this month. Bespak now has a strongmanagement team to take the business forward." For further information, please contact: Bespak plc Tel: +44 (0) 1908 525 240Mark Throdahl - Chief ExecutiveJon Glenn - Finance Director Maitland Tel: +44 (0) 207 379 5151Brian Hudspith Liz Morley This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
CSRT.L